News
Publications
Multimedia
Conferences
Webcasts
Resources
Subscribe

Spotlight -

Drug Development|

Quality Systems

Emily Schirmer, Catalent

Articles by Emily Schirmer, Catalent

How Biologic Developers Use Optimized Platforms and Operations to Reach First-in-Human Trials

ByEmily Schirmer, Catalent,Jeanne Linke Northrop, Pharmaceutical Technology

May 13th 2026

Sponsored

Emily Schirmer, Catalent, explains how to accelerate the path to first-in-human trials as biologics pipelines grow more complex and timelines tighten.

Latest Updated Articles

Trending on Pharmaceutical Technology

PharmTech Weekly Roundup—June 5, 2026

Generic GLP-1s Enter Canadian Market

Tom Sellig on CDMO Innovation and US Manufacturing Growth

Viral Safety 2.0: Plant-Ready Actions for ICH Q5A(R2) Compliance

FDA Guidance for Accelerating Gene Therapies for Rare Diseases